Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LOC14 是一种蛋白质二硫键异构酶抑制剂 (EC50=500 nM;Kd=62 nM)。它抑制 PDIA3 活性,降低肺上皮细胞中 HA 的分子内二硫键和随后的寡聚化。它在小鼠肝微粒体和血浆中表现出高稳定性,低内在微粒体清除率和低血浆蛋白结合。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 295 | 现货 | ||
5 mg | ¥ 828 | 现货 | ||
10 mg | ¥ 1,350 | 现货 | ||
25 mg | ¥ 2,650 | 现货 | ||
50 mg | ¥ 3,880 | 现货 | ||
100 mg | ¥ 5,490 | 现货 |
产品描述 | LOC14 to be the most potent PDI inhibitor reported to date( EC50 : 500 nM) |
靶点活性 | PDI:500 nM(EC50) |
体外活性 | LOC14引起的PDI氧化,在细胞培养中不仅具有神经保护作用,而且在皮质纹状体脑片培养中也表现出同样效果[1]。 |
体内活性 | LOC14 在肝微粒体和血浆中显示出高稳定性,小鼠以高剂量20 mg/kg耐受良好,并能够在体内穿透血脑屏障(BBB)[1][2]。 |
动物实验 | LOC14 levels were measured in mouse plasma, striatum and cerebral cortex using Ultra Performance Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).?LOC14 was extracted from mouse plasma by mixing 100 μl of plasma with 900 μl of cold acetonitrile containing 25 ng/ml of cyclocreatine as an internal standard.?After mixing for 5 min. the sample was centrifuged for 10min and the organic layer was transferred to an LC-MS vial and dried under nitrogen.?The sample was reconstituted in 100 μl of 50% acetonitrile and 5 μl was injected onto the LC-MS.?Brain tissue samples were homogenized using a tissue tearor at a concentration of 150 mg/ml in cold LC-MS water followed by extraction with 1.8 ml of cold acetonitrile containing the cyclocreatine internal standard.?The brain samples were mixed and centrifuged and reconstituted the same as for the plasma samples[2]. |
分子量 | 317.41 |
分子式 | C16H19N3O2S |
CAS No. | 877963-94-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (78.76 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.1505 mL | 15.7525 mL | 31.505 mL | 78.7625 mL |
5 mM | 0.6301 mL | 3.1505 mL | 6.301 mL | 15.7525 mL | |
10 mM | 0.315 mL | 1.5752 mL | 3.1505 mL | 7.8762 mL | |
20 mM | 0.1575 mL | 0.7876 mL | 1.5752 mL | 3.9381 mL | |
50 mM | 0.063 mL | 0.315 mL | 0.6301 mL | 1.5752 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
LOC14 877963-94-5 Others LOC-14 inhibit LOC 14 Inhibitor inhibitor